TNNT1 myopathy natural history study
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study follows people with a rare genetic muscle condition called TNNT1 myopathy over time. Researchers will track how the disease progresses to better understand it and help plan future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with a change in both copies of the TNNT1 gene (the gene linked to this condition).
- Muscle weakness must have started in infancy or early childhood.
- You cannot have any other medical condition that could affect the course of the disease or interfere with study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This natural history study follows children and adults with suspected or confirmed mitochondrial myopathy to better understand symptoms and how the condition changes. It may also include healthy participants to compare test results and improve future treatments.
This study creates a network to gather information about people with nemaline myopathy, a genetic muscle disorder. It aims to improve understanding and support for future research and care.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
This study follows people with CTNNB1 syndrome over time to better understand the condition. It does not test any new treatment—just collects information to help future research.
This study tracks the health of people with nemaline myopathy over time to learn more about how the condition progresses. By joining, you help researchers understand the disease better, which may support future care and treatment development.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
Hear when a new Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.